InnoCare Pharma
(1)2024
(2)2024
(3)
(4)2024
(5)2024
(6)2024121788EGM-1EGM-2
(www.hkexnews.hk)(www.innocarepharma.com)
4820241215
18317M20241215
20241128
– i –
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8
1.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9
3.2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
4.2024 . . . . . .51
5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .54
6.2024
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7.2024. . . . . . . . . . . . .57
8. . . .59
9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
12.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .63
13. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
14. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
– ii –
— 2024. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-1
— . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .II-1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .EGM-1
(www.hkexnews.hk)(www.innocarepharma.com)
4820241215
17M20241215
183171712–1716
(852) 2862 8555
(852) 2865 0990
www.computershare.com/hk/contact
(www.hkexnews.hk)(www.sse.com.cn)(www.innocarepharma.com)
20232023622023
20235
20232023831
202381620242024
14A.06(2)
20151139969
688428
20241217
9,870,200
80%
6.65
—
0.000002
2024
5%
2024
(i)
0.1%(ii)
(iii)
XIVA
20241126
2,467,550
20%
0.000002
6.2024
0.000002
%
InnoCare Pharma
Ogier Global (Cayman) Limited89 Nexus Way, Camana BayGrand Cayman, KY1-9009Cayman Islands
(1)2024
(2)2024
(3)
(4)2024
(5)2024
(6)
1.
EGM-1EGM-2
(1)2024(2)2024
(3)(4)2024(5)20242.
(i)202383120238312023(ii)202362
2023(iii)20234282023
(i)202381620232023(ii)2023532023
2023
20232023
3.43%60,430,357(i)20232023
(ii)20232023
2023
2.92%51,481,6070.51%
8,948,7503.43%
1,764,321,4521,762,567,202
3.43%
2023(i)7,209,000(ii)1,737,000(iii)(a)2023(b)2,750202312
3. 2024
20241126202420242024
I.20242024
2024112620242024
20242024
2024
2024I. 2024
2023
2024202412,337,7500.70%
6.2024
202420%202410%2024
1%
0.1%
II.(I)
(II)
III.
1,233.775176,256.72020.70%
987.020
176,256.72020.56%
80.00%246.755
176,256.72020.14%
20.00%
IV.
(I)
1.
2.
5%
20242023
(II)
79202312311,0897.25%
1.2.
5%
(III)
0.1%
4.20248.
— (i)
1.
258.0020.91%0.15%
70.005.67%0.04%
60.004.86%0.03%
10.000.81%0.01%
398.0032.26%0.23%
2.
75589.0247.74%0.33%
987.0280.00%0.56%
3. 246.75520.00%0.14%
1,233.775100.00%0.70%
1%
0.1%
20%20232023
10%
5%
(IV)
1.
2. 5
V.(I)
(II)
1212
1.
(1)
(2)
2.
(III)
1.
2.
3.
4.
25%
25%
25%
25%
2025
25%
25%
25%
25%
2025
25%
25%
25%
25%
2024
(IV)
—
1.
25%
2.
—
VI.(I)
6.65
6.65
(II)
1. 1
12.9550.00%6.47
2. 20
2020
13.3050.00%6.65
3. 60
6060
12.5450.00%6.27
4. 120
120120
10.8150.00%5.40(i)2024(ii)2024VII.(I)
1.
(1)
(2)
(3) 36
(4)(5)2.
(1) 12
(2) 12
(3) 12
(4)
(5)(6)
(II)
1.
(1)
(2)
(3) 36
(4)(5)2.
(1) 12
(2) 12
(3) 12
(4)
(5)(6)
2024202420243.
4.
2025–2028
A100%
B80%
C70%2025
1. 2025
1. 2025
17.5
1. 2025
2. 20258
IIIIII
2. 20257
IIIIII
2. 20256
IIIIII
2026
1. 2025–2026
1. 2025–2026
47.5
1. 2025–2026
2. 2025–2026
IIIIII
2. 2025–2026
IIIIII
2. 2025–2026
IIIIII
A100%
B80%
C70%2027
1. 2025–2027
1. 2025–2027
87.5
1. 2025–2027
2. 2025–2027
IIIIII
2. 2025–2027
IIIIII
2. 2025–2027
IIIIII
2028
1. 2025–2028
1. 2025–2028
137.5
1. 2025–2028
2. 2025–2028
IIIIII
2. 2025–2028
IIIIII
2. 2025–2028
IIIIII
20252025–2028
20252026–2029
A100%
B80%
C70%2026
1. 2025–2026
1. 2025–2026
47.5
1. 2025–2026
2. 2025–2026
IIIIII
2. 2025–2026
IIIIII
2. 2025–2026
IIIIII
A100%
B80%
C70%2027
1. 2025–2027
1. 2025–2027
87.5
1. 2025–2027
2. 2025–2027
IIIIII
2. 2025–2027
IIIIII
2. 2025–2027
IIIIII
2028
1. 2025–2028
1. 2025–2028
137.5
1. 2025–2028
2. 2025–2028
IIIIII
2. 2025–2028
IIIIII
2. 2025–2028
IIIIII
A100%
B80%
C70%2029
1. 2025–2029
1. 2025–2029
197.5
1. 2025–2029
2. 2025–2029
IIIIII
2. 2025–2029
IIIIII
2. 2025–2029
IIIIII
5.
ME & ME AboveME-BE
ME & MEAboveME-BE100%80%0
=
(III)
2024VIII.
(I)
1.2.
3.
4. 6
5.
6.7.
5%
0.1%
8.
(II)
1.
2.
3.
4. 60
(III)
1.
2.
(IV)
1.
2.
(1)(2)
3.
(V)
1.
2.
3.
IX.(I)
1.
Q Q
(1 n)Q
nQ2.
Q Q
P
(1 n) (P
P
n)Q
P
P
nQ3.
Q Q
nQ
n1nQ4.
(II)
1.
P P
(1 n)P
nP
2.
P P
(P
P
n) [P
(1 n)]P
P
P
nP
3.
P P
nP
nP4.
P P
– VP
VPP15.
(III)
X.
—
—
(I)
—
—
—
Black-Scholes20241126987.02
1. 12.812024
1126
2. 17294153
3. 35.2014%33.7426%34.8850%35.5328%
17294153
4. 1.3603%1.3852%1.4451%1.5554%
1234(II)
202412
202420252026202720282029
987.026,657.45111.572,677.561,984.111,148.13586.08150.01
1.
2.
XI.(I)
1.
2.
3.
4.
5.
6.
7.
8.
(II)
1.
2.3.
4.
5.
6.
7.
8.
9.XII.(I)
1.
(1)
(2)
(3) 36
(4)(5)
2.
(1)
(2)3.
(II)
1.
(1) 12
(2) 12
(3) 12
(4)
(5)
(6)
2.
3.
4.
5.
(1)
(2)
6.
(1)
(2)
7.(III)
4. 2024
20242024
120.1%
3.2024
2024
2,580,000
6.65
(i) 6.16(ii) 12.8113.86
2024
25%
2025
2024
2024
(i)
2024
(ii)
2024
8.
— (i)
5.
6. 2024
12,337,750
0.70%
4.13%
3.2024
2024
82,046,037.5012,337,7502024
6.65
VI.
0.000002
24.6755
(1)266,282,967278,620,7171,496,284,2351,496,284,235
1,762,567,2021,774,904,952
1.
(1)
75.83%75.82%
1.1212
7. 2024
202420241.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
8.
(i)
17.04(1)2024
17.04(2)17.04(4)
0.15%0.1%
100,951,4165.73%
(i)
121%(ii)
0.1%
(ii)
17.03(13)
17.03(13)17.03(13)
2024111417.03(13)
(i)2024
2024
(ii)
(iii)12,337,7501,762,567,202
0.70%(iv)
(iii)
20241114
8.2013.26(1)2024
(a) 6.12
(i)75%(ii)
6.12(1)
10%(b) 6.15
(c) 13.36(2)(b)
10%9.
(1)2024
(2)(3)2024(4)2024
2,580,000(5)202420241217
EGM-1EGM-2
(http://www.hkexnews.hk)(www.innocarepharma.com)10.
2024121220241217
20241211
183171712–1716
11.
2024
EGM-1EGM-2
12.
(i)20242,580,0004(ii)
(1)2024
(2)(3)2024
(5)2024
17.05A
8,318,000
13.
2024
2024
14.
20241128
2024
– I-1 –
A688428 A
09969
2024
2024
– I-2 –
—
2024
– I-3 –
1,233.775
176,256.72020.70%
987.02
176,256.72020.56%80.00%
246.755
176,256.72020.14%20.00%
20%10%1%
120.1%
6.65
2024
– I-4 –
7920231231
1,0897.25%
2024
– I-5 –
12 12 12
2024
– I-6 –
2024
– I-7 –
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-13 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-14 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-15 . . . . . . . . . . . . . . . . . . . . . .I-17 . . . . . . . . . . . . . . . .I-20 . . . . . . . . . . . . . . . . . . . .I-26 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-39 . . . . . . . . . . . . . . . . . . . . . . . . . .I-43
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-48
2024
– I-8 –
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-50 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .I-55
2024
– I-9 –
InnoCare Pharma Limited
2024
2024
– I-10 –
202411262015 201696
2016 201696
2018 20181128
20152016
2018
20232023622023
20232023831
2024
– I-11 –
20242024328
(i)
0.1%
(ii)(iii)
—
(InnoCare Pharma Limited)
2024
– I-12 –
2024
– I-13 –
202320232024
20238112023831
(1)2023
8,948,7508,946,0002,750
(2)2023
51,481,607
(3)2024
176,258,245
20%
10%
2024
– I-14 –
0.1%
2024
– I-15 –
Jisong CuiRenbin Zhao
5%
79202312311,0897.25%
2024
– I-16 –
Jisong CuiRenbin Zhao5%Jisong CuiRenbin Zhao
Jisong CuiRenbin Zhao
2024
– I-17 –
1,233.775176,256.72020.70%987.02
176,256.72020.56%
80.00%246.755
176,256.72020.14%20.00%
2024
– I-18 –
Jisong Cui0.1%
120.1%
Jisong Cui 258.0020.91%0.15%
Xiangyang Chen70.005.67%0.04%Renbin Zhao
60.004.86%0.03%
10.000.81%0.01%
398.0032.26%0.23%
2024
– I-19 –
589.0247.74%0.33%
987.0280.00%0.56%
246.75520.00%0.14%1,233.775100.00%0.70%
1%
120.1%
20%10%2 Jisong CuiRenbin Zhao
5%
2024
– I-20 –
1212
2024
– I-21 –
2024
– I-22 –
25%
25%
25%
25%
2024
– I-23 –
2025
25%
25%
25%
25%
2024
– I-24 –
2025
25%
25%
25%
25%
2024
– I-25 –
—
25%
—
2024
– I-26 –
6.65
6.65
112.9550.00%
6.47
20202013.30
50.00%6.65
60606012.54
50.00%6.27
2024
– I-27 –
12012012010.81
50.00%5.40
3 36
1 12
2024
– I-28 –
2 123 12
3 36
2024
– I-29 –
1 122 123 12
2024
– I-30 –
2025–2028
A100%
B80%
C70%2025
1 2025
2 20258
I-III
1 2025
17.5
2 20257
I-III
1 2025
2 20256
I-III
2024
– I-31 –
A100%
B80%
C70%2026
1 2025–2026
2 2025–2026
I-III
1 2025–2026
47.5
2 2025–2026
I-III
1 2025–2026
2 2025–2026
I-III
2024
– I-32 –
A100%
B80%
C70%2027
1 2025–2027
2 2025–2027
I-III
1 2025–2027
87.5
2 2025–2027
I-III
1 2025–2027
2 2025–2027
I-III
2024
– I-33 –
A100%
B80%
C70%2028
1 2025–2028
2 2025–2028
I-III
1 2025–2028
137.5
2 2025–2028
I-III
1 2025–2028
2 2025–2028
I-III
2024
– I-34 –
20252025–202820252026–2029
A100%
B80%
C70%2026
1 2025–2026
2 2025–2026
I-III
1 2025–2026
47.5
2 2025–2026
I-III
1 2025–2026
2 2025–2026
I-III
2024
– I-35 –
A100%
B80%
C70%2027
1 2025–2027
2 2025–2027
I-III
1 2025–2027
87.5
2 2025–2027
I-III
1 2025–2027
2 2025–2027
I-III
2024
– I-36 –
A100%
B80%
C70%2028
1 2025–2028
2 2025–2028
I-III
1 2025–2028
137.5
2 2025–2028
I-III
1 2025–2028
2 2025–2028
I-III
2024
– I-37 –
A100%
B80%
C70%2029
1 2025–2029
2 2025–2029
I-III
1 2025–2029
197.5
2 2025–2029
I-III
1 2025–2029
2 2025–2029
I-III
2024
– I-38 –
ME & ME AboveME-BE
ME & MEAboveME-BE100%80%0=
2024
– I-39 –
2024
– I-40 –
5%
0.1%
2024
– I-41 –
2024
– I-42 –
2024
– I-43 –
(1n)Q
nQ
P
(1n)(P
P
n)Q
P
P
nQ
2024
– I-44 –
nQ
n1nQ
PP
(1n)P
nP
PP
(P
P
n)[P
(1n)]P
P
P
nP
2024
– I-45 –
PP
nP
nP
PP
–VP
VPP1
—
—
2024
– I-46 –
—
—
—
Black-Scholes20241126
987.02
12.8120241126 17294153
35.2014%33.7426%34.8850% 35.5328%
17294153 1.3603%1.3852%1.4451%1.5554%12
2024
– I-47 –
202412
202420252026202720282029
987.026,657.45111.572,677.561,984.111,148.13586.08150.01
2024
– I-48 –
2024
– I-49 –
2024
– I-50 –
2024
– I-51 –
3 36
1 12
2024
– I-52 –
2 123 12
2024
– I-53 –
2024
– I-54 –
2024
– I-55 –
20241126
– II-1 –
2024
2024
—
– II-2 –
– II-3 –
2025–2028
A100%
B80%
C70%2025
1 2025
2 20258
I-III
1 2025
17.5
2 20257
I-III
1 2025
2 20256
I-III
– II-4 –
A100%
B80%
C70%2026
1 2025–2026
2 2025–2026
I-III
1 2025–2026
47.5
2 2025–2026
I-III
1 2025–2026
2 2025–2026
I-III
– II-5 –
A100%
B80%
C70%2027
1 2025–2027
2 2025–2027
I-III
1 2025–2027
87.5
2 2025–2027
I-III
1 2025–2027
2 2025–2027
I-III
– II-6 –
A100%
B80%
C70%2028
1 2025–2028
2 2025–2028
I-III
1 2025–2028
137.5
2 2025–2028
I-III
1 2025–2028
2 2025–2028
I-III
20252025–2028
– II-7 –
20252026-2029
A100%
B80%
C70%2026
1 2025–2026
2 2025–2026
I-III
1 2025–2026
47.5
2 2025–2026
I-III
1 2025–2026
2 2025–2026
I-III
– II-8 –
A100%
B80%
C70%2027
1 2025–2027
2 2025–2027
I-III
1 2025–2027
87.5
2 2025–2027
I-III
1 2025–2027
2 2025–2027
I-III
– II-9 –
A100%
B80%
C70%2028
1 2025–2028
2 2025–2028
I-III
1 2025–2028
137.5
2 2025–2028
I-III
1 2025–2028
2 2025–2028
I-III
– II-10 –
A100%
B80%
C70%2029
1 2025–2029
2 2025–2029
I-III
1 2025–2029
197.5
2 2025–2029
I-III
1 2025–2029
2 2025–2029
I-III
ME & ME AboveME-BE
– II-11 –
ME & MEAboveME-BE100%80%0=
20252025–2028
20252026-2029
– II-12 –
20241126
– EGM-1 –
InnoCare Pharma
20241217
1. 20242.
3. 2024
4. 20242,580,000
5. 2024
20241128
– EGM-2 –
1. 202411282.
3. 20241212
20241217
202412
183171712–17164.
5.
6.
(48)18317M202412157.8.
9.
www.innocarepharma.com www.hkexnews.hkwww.sse.com.cn10.